Repare Therapeutics Inc (RPTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2017 | 12-2006 | |
| Cash Flows From Operating Activities | |||
| Net Income | -27,216 | N/A | N/A |
| Depreciation Amortization | 605 | N/A | N/A |
| Accounts receivable | -1,913 | N/A | N/A |
| Accounts payable and accrued liabilities | 833 | N/A | N/A |
| Other Working Capital | 6,588 | N/A | N/A |
| Other Operating Activity | 2,674 | 0 | 0 |
| Operating Cash Flow | $-18,429 | $N/A | $N/A |
| Cash Flows From Investing Activities | |||
| PPE Investments | -1,304 | N/A | N/A |
| Investing Cash Flow | $-1,304 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||
| Other Financing Activity | 103,243 | 0 | 0 |
| Financing Cash Flow | $103,243 | $N/A | $N/A |
| Exchange Rate Effect | 566 | N/A | N/A |
| Beginning Cash Position | 10,929 | N/A | N/A |
| End Cash Position | 95,005 | N/A | N/A |
| Net Cash Flow | $84,076 | $N/A | $N/A |
| Free Cash Flow | |||
| Operating Cash Flow | -18,429 | N/A | N/A |
| Capital Expenditure | -1,304 | N/A | N/A |
| Free Cash Flow | -19,733 | 0 | 0 |